Plexcera Therapeutics has received approval from Mount Sinai Innovation Partners (MSIP), part of the Icahn School of Medicine, to develop recombinant human acid ceramidase (rhAC) for treatment of diseases caused by genetic or ...
Tags: Plexcera, Cystic Fibrosis
Shire, a specialty biopharmaceutical company, is set to purchase US-based biotechnology company Lotus Tissue Repair. Under the purchase, Lotus Tissue Repair's intravenous protein replacement therapy, which is in late pre-clinical ...
Tags: Shire, biopharmaceutical company, US, Lotus Tissue Repair
Insmed, a biopharmaceutical company developing inhalation therapeutics for patients suffering from orphan lung diseases, has named Will Lewis as president and chief executive officer. Lewis has also been appointed to the company's board ...
Acceleron Pharma, a developer of protein therapeutics for cancer and orphan diseases, has entered into a collaboration agreement to deploy QUMAS' DocCompliance to manage all of its regulatory documents, following an extensive vendor ...
Tags: Acceleron Pharma, cancer, orphan diseases, collaboration agreement